Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)
Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004
New York 2004
Available at
FM - Fac. Medicina
(BCSEP 2004 65 ) and other locations(GetIt)
The occluded artery trial(OAT)viability ancillary study(OAT-NUC) influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone
James E. Udelson Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Anna Teresinska; Bartosz Bychowiec; José Antônio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt Sadowski; Witold Ruzyllo; Sandy A Forman; Debora J Kinan; Gervasio A Lamas; Judith S Hochman; Scientific Sessions of The American Heart Association(AHA) (2007 Orlando)
Abstracts Orlando, 2007
Orlando 2007
Available at
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 1642665 ) and other locations(GetIt)
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau
Infarct size, viability, and correlates in patients presenting with a persistent total occlusion of the infarct-related artery 3-28 days post myocardial infarction an occluded artery trial (OAT) substudy
Camille A. Pearle James E Udelson; Mariusz Kruk; Harmony R Reynolds; Witold Ruzyllo; Zygmund Sadowski; Anna Teresinska; Barbosz Bychowiec; Thomas Höchtl; José Antonio Marin Neto; Eric A Cohen; Benita Busz Papiez; Paulo Caramori; Gervasio A Adilbrecht; Carey Kimmelstiel; Christopher E Buller; Sandra Forman; Gervasio A Lamas; Judith S Hochman; Annual Scientific Session (56. 2007 New York)
Journal of American College Cardiology New York v. 49, n. 9, on-line, 2007
New York 2007
Available at
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 1647082 ) and other locations(GetIt)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger
American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005
Orlando 2005
Available at
FM - Fac. Medicina
(FM BCBIB )(GetIt)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger
American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005
Orlando 2005
Available at
FM - Fac. Medicina
(FM BCBIB )(GetIt)
The occluded artery trial (OAT) viability ancillary study (OAT-NUC) influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone
James E. Udelson Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; José Antonio Marin Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman
American Heart Journal Philadelphia v. 161, n. 3, p. 611-621, 2011
Philadelphia 2011
Available at
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2282312 Estantes Deslizantes )(GetIt)
Home Page
RSS
Feed
Policies
Contact Us
Social Network Logos: 